Information  X 
Enter a valid email address

Broker Forecast - UBS issues a broker note on GlaxoSmithKline PLC

By BFN News | 08:40 AM | Friday 31 January, 2020

UBS today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1950p (from 1900p). Story provided by Broker Forecasts data provided by

a d v e r t i s e m e n t